1. Home
  2. HRTX vs ALIS Comparison

HRTX vs ALIS Comparison

Compare HRTX & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

HOLD

Current Price

$0.33

Market Cap

90.1M

Sector

Health Care

ML Signal

HOLD

ALIS

Calisa Acquisition Corp Ordinary shares

N/A

Current Price

$10.20

Market Cap

85.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HRTX
ALIS
Founded
1983
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.1M
85.9M
IPO Year
2007
2024

Fundamental Metrics

Financial Performance
Metric
HRTX
ALIS
Price
$0.33
$10.20
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
2.7M
52.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
$154,904,000.00
N/A
Revenue This Year
$15.28
N/A
Revenue Next Year
$20.29
N/A
P/E Ratio
N/A
$254.75
Revenue Growth
7.36
N/A
52 Week Low
$0.30
$9.87
52 Week High
$1.58
$10.25

Technical Indicators

Market Signals
Indicator
HRTX
ALIS
Relative Strength Index (RSI) 27.65 63.17
Support Level N/A $10.05
Resistance Level $0.46 $10.21
Average True Range (ATR) 0.04 0.01
MACD -0.02 0.00
Stochastic Oscillator 11.40 80.00

Price Performance

Historical Comparison
HRTX
ALIS

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About ALIS Calisa Acquisition Corp Ordinary shares

Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.

Share on Social Networks: